Mikhail Blagosklonny is an Oncology professor and scientist studying aging and cancer. Mikhail has worked in different places and has gained skills and experienced making him an exceptional professor.
Blagosklonny’s Career and Education Background
Mikhail holds an MD in Internal Medicine from the First Pavlov State Medical University of St. Petersburg. At Pavlov State University, he also obtained a Ph.D. in Cardiology and Experimental Medicine. In 2002, Mikhail had the opportunity to work at New York Medical College as an associate professor of Medicine. Later on, he moved on to Ordway Research Institute as a senior scientist. In 2009, Mikhail became an Oncology Professor at the Roswell Park Cancer Institute. Blagosklonny also serves as an associate editor for International Journal of Cancer, PLOS ONE and the American Journal of Pathology.
Mikhail’s research is based on cancer, anti-aging drugs, Biogerontology and cancer therapies that guard the cells of a healthy human body against damage. Mr. Blagosklonny is the editor-in-chief of Cell Cycle and Oncotarget. Oncotarget is a medical journal that was launched in 2010. This medical journal focuses on Oncology research and is published weekly. Mikhail is the associate editor of therapy and cancer biology. He sits on the editorial board of Cell Differentiation and Death.
Blagosklonny Works and Teachings
Mikhail Blagosklonny teaches Oncology at the Roswell Park Cancer Institute. He has proposed the use of Rapamycin which is a popular drug that is utilized in treating cancer. Mikhail has been classified as the most passionate researcher of Rapamycin. His research includes clinical investigations, molecular biology, and cellular biology. The study consists of tumor suppressors, ontogenesis, apoptosis, mitosis, cell cycle, anticancer therapeutics and signal transduction. Mikhail focuses on aging hyperfunction theory as an author.
Blagosklonny also focuses on chemotherapeutic engineering and cell cyclotherapay. However, Blagosklonny’s main interest lies in Oncology. According Mikhail, cancer and aging can be controlled through treatment. He has published three hundred book chapters research articles and reviews.
Mikhail is a hard working scientist who is currently among the leading Oncology researchers worldwide. His love for the human race and vision of a community free from diseases drove him to venture into the Oncology sector. Read more about Mikhail at LinkedIn.com